关于假冒胰岛素产品的声明

诺和诺德(中国)制药有限公司(“公司”)一直致力于为患者提供高质量的药品,并确保患者的使用安全。近期,个别地方的患者向公司反映,在当地药店购买的胰岛素笔芯产品使用后发现血糖升高。经公司调查,已经确认这些胰岛素产品非公司生产,而是假冒产品。公司已向当地执法机关报告了前述情况,相关调查正在进行中。

公司提醒广大消费者一定要到正规的医院和药店购买公司产品。如果您怀疑买到了假冒产品,请暂停使用该产品并立即向当地药监局举报。

Announcement

Novo Nordisk (China) Pharmaceuticals Co., Ltd. (the “Company”) is committed to providing high quality drugs and to safeguarding patient safety. Recently the Company was contacted by some patients stating that the blood glucose was increasing after using insulin Penfill products. The suspected Penfills were bought in local pharmacies. Following an investigation, Novo Nordisk has identified that the suspected Penfill products are not produced by the Company but are counterfeits. Novo Nordisk has reported these incidents of counterfeit insulin Penfill to local regulatory authorities, and investigations are being carried out.

The Company reminds the customers to buy Novo Nordisk's products from normal hospitals or pharmacies, instead of from any illegal source. If you find any products to be suspected, please stop using it and contact your local regulatory authorities immediately.


媒体联络

 

刘颀  企业交流副总监

人力资源与企业交流部

联系电话:

(86) 10-59615614

 

常乐  公共关系项目经理

人力资源与企业交流部

联系电话:

(86) 10-59615780